Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $223,008 - $266,110
-4,600 Reduced 25.7%
13,300 $682,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $1.14 Million - $1.27 Million
17,900 New
17,900 $1.14 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alphadyne Asset Management LP Portfolio

Follow Alphadyne Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphadyne Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Alphadyne Asset Management LP with notifications on news.